Depression and Anxiety Trial, Recruiting NCT07369557 Sponsor: Medical University of South Carolina Condition: Depression and Anxiety
Back to Depression And Anxiety

Depression and Anxiety Trial, Recruiting

NCT07369557
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been clinically diagnosed with major depressive disorder (a serious form of depression) and have been accepted for a specific type of brain stimulation treatment called aiTBS at MUSC (Medical University of South Carolina)
  • People who are already enrolled in an aiTBS treatment course at MUSC
  • People who are able to communicate and read in English
  • People who own a smartphone, or who are willing to use a device provided by the study

Who may not be able to join:

  • People for whom TMS (transcranial magnetic stimulation, a type of brain stimulation) is considered medically unsafe — for example, those with a history of seizures, certain metal implants in the body, or who are pregnant
  • People who are currently receiving other types of brain or nerve stimulation treatments, such as ECT (electroconvulsive therapy) or VNS (vagus nerve stimulation)
  • People who have been diagnosed with a psychotic disorder, bipolar disorder, an active substance use disorder, or who are considered to be at high risk of suicide
  • People who are unwilling or unable to take part in mindfulness exercises or to fill out study questionnaires

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 19 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
13 April 2026
Est. completion
30 September 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Feasibility of Guided Mindfulness Practice During aiTBS (Adherence Rate); Tolerability of Guided Mindfulness Practice During aiTBS (Adverse Events)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov